Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Benoît Laflaquière"'
Autor:
Benoît Laflaquière, Gabrielle Leclercq, Chandarong Choey, Jingkui Chen, Sabine Peres, Caryn Ito, Mario Jolicoeur
Publikováno v:
Metabolites, Vol 8, Iss 1, p 18 (2018)
Because of their unique ability to modulate the immune system, mesenchymal stromal cells (MSCs) are widely studied to develop cell therapies for detrimental immune and inflammatory disorders. However, controlling the final cell phenotype and determin
Externí odkaz:
https://doaj.org/article/654fef3a5303418e8ba460eab7d334a2
Autor:
Sabine Peres, Gabrielle Leclercq, Chandarong Choey, Benoît Laflaquière, Caryn Ito, Jingkui Chen, Mario Jolicoeur
Publikováno v:
Metabolites; Volume 8; Issue 1; Pages: 18
Metabolites
Metabolites, MDPI, 2018, 8 (1), ⟨10.3390/metabo8010018⟩
Metabolites, MDPI, 2018, 8 (1), pp.18. ⟨10.3390/metabo8010018⟩
www.mdpi.com/journal/metabolites
Metabolites, Vol 8, Iss 1, p 18 (2018)
Metabolites
Metabolites, MDPI, 2018, 8 (1), ⟨10.3390/metabo8010018⟩
Metabolites, MDPI, 2018, 8 (1), pp.18. ⟨10.3390/metabo8010018⟩
www.mdpi.com/journal/metabolites
Metabolites, Vol 8, Iss 1, p 18 (2018)
International audience; Because of their unique ability to modulate the immune system, mesenchymal stromal cells (MSCs) are widely studied to develop cell therapies for detrimental immune and inflammatory disorders. However, controlling the final cel